Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostic products, today announced the launch of the Foresight™ Pro 45 cm internal diameter (ID) chromatography column designed to support: I did it. Chromatography applications at downstream process scale across various stages of biological drug production.
Bio-Rad expands its portfolio Foresight Pro columns With internal diameters ranging from 5 to 33 cm, the new 45 cm ID Foresight Pro columns provide biopharmaceutical manufacturers with an easily integrated solution for the downstream purification of biomolecules, including vaccines, antibodies and recombinant proteins. Foresight Pro columns are manufactured and packaged in a controlled ISO Class 7 cleanroom, providing Good Manufacturing Practices (GMP) ready columns. Standardized designs and formats in a variety of diameters and bed heights provide convenient and reliable solutions packaged in CHT™ Ceramic Hydroxyapatite Media Type I, Type II or XT. Bio-Rad’s CHT media is a robust mixed-mode support media for biomolecule purification. Ca, a unique component of CHT10(PO4)6oh2Biomolecules can interact with the medium through metal affinity interactions through calcium atoms and/or cation exchange interactions through phosphate groups.
“Building on the successful acceptance of our initial range of 5-33 cm ID columns launched in 2022, the new 45 cm ID Foresight Pro column is Bio-Rad’s answer to our customers’ requests for larger columns,” said Process Director. Diab Elmashni said. Chromatography Project of Bio-Rad Laboratories. “This column is unique in the market in that it is packaged in a single lot of Bio-Rad’s CHT media. Different suppliers may combine different batches of resin when packaging their columns. Bio-Rad’s Foresight Pro columns are therefore a unique, single-source solution that delivers unmatched technical, application and product support advantages to the biopharmaceutical industry.”
